TR201818307A2 - Di̇meti̇l fumarat i̇çeren bi̇r kompozi̇syon - Google Patents

Di̇meti̇l fumarat i̇çeren bi̇r kompozi̇syon

Info

Publication number
TR201818307A2
TR201818307A2 TR2018/18307A TR201818307A TR201818307A2 TR 201818307 A2 TR201818307 A2 TR 201818307A2 TR 2018/18307 A TR2018/18307 A TR 2018/18307A TR 201818307 A TR201818307 A TR 201818307A TR 201818307 A2 TR201818307 A2 TR 201818307A2
Authority
TR
Turkey
Prior art keywords
dimethyl fumarate
composition containing
containing dimethyl
pharmaceutically acceptable
pharmaceutical composition
Prior art date
Application number
TR2018/18307A
Other languages
English (en)
Inventor
Güner Di̇cle
Mollaoğlu Fati̇h
Palantöken Arzu
Türkyilmaz Ali̇
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2018/18307A priority Critical patent/TR201818307A2/tr
Priority to PCT/TR2019/050965 priority patent/WO2020112060A1/en
Publication of TR201818307A2 publication Critical patent/TR201818307A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mevcut buluş; dimetil fumarat, en az bir farmasötik olarak kabul edilebilir eksipiyan ve en az iki kaplama katmanına sahip kaplı pelletler içeren bir farmasötik kompozisyon ile ilgilidir.
TR2018/18307A 2018-11-30 2018-11-30 Di̇meti̇l fumarat i̇çeren bi̇r kompozi̇syon TR201818307A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2018/18307A TR201818307A2 (tr) 2018-11-30 2018-11-30 Di̇meti̇l fumarat i̇çeren bi̇r kompozi̇syon
PCT/TR2019/050965 WO2020112060A1 (en) 2018-11-30 2019-11-18 A composition comprising dimethyl fumarate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2018/18307A TR201818307A2 (tr) 2018-11-30 2018-11-30 Di̇meti̇l fumarat i̇çeren bi̇r kompozi̇syon

Publications (1)

Publication Number Publication Date
TR201818307A2 true TR201818307A2 (tr) 2020-06-22

Family

ID=70854331

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/18307A TR201818307A2 (tr) 2018-11-30 2018-11-30 Di̇meti̇l fumarat i̇çeren bi̇r kompozi̇syon

Country Status (2)

Country Link
TR (1) TR201818307A2 (tr)
WO (1) WO2020112060A1 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023014395A (es) 2021-06-04 2023-12-15 Zim Laboratories Ltd Composiciones de liberacion retardada de dimetilfumarato.
CN116251074B (zh) * 2023-04-19 2025-02-11 四川宏明博思药业有限公司 一种富马酸二甲酯肠溶片以及肠溶胶囊

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017009289A2 (pt) * 2014-11-04 2017-12-19 Adamas Pharmaceuticals Inc métodos de administrar composições de amantadina
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle

Also Published As

Publication number Publication date
WO2020112060A1 (en) 2020-06-04

Similar Documents

Publication Publication Date Title
MX2023013096A (es) Uso farmaceutico de compuesto de peptidos ciclicos.
ECSP20025899A (es) Compuestos útiles para inhibir a cdk7
CY1122730T1 (el) 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων
HUE054690T2 (hu) 8-Oxetán-3-il-3,8-diazabiciklo[3.2.1]oktán-3-il-csoporttal szubsztituált vegyületek HIV inhibitorokként
CL2015002472A1 (es) Como inhibidores de mutant idh-yl-oxazolidin-2-onas 3-pirimidin-4.
EA201691194A1 (ru) Стимуляторы ргц
BR112016028288A2 (pt) ?composto, composição farmacêutica, métodos para tratamento de um indivíduo com uma doença ou condição e para inibir a quinase, e, uso de um composto?
ECSP21053104A (es) Moduladores de la expresión de hsd17b13
EA201690679A1 (ru) Стабильная фармацевтическая композиция, содержащая амлодипин и валсартан
EA201790627A1 (ru) СТИМУЛЯТОРЫ рГЦ
ECSP17044282A (es) Formulación de relación fija de insulina glargina/lixisenatida
CY1123871T1 (el) Ανταγωνιστες ιντεγκρινης
MX2019010950A (es) Composicion de fotosensibilizador que contiene fenalen-1-ona, compuesto de fenalen-1-ona, asi como su uso.
TR201916829A2 (tr) Dapagli̇flozi̇n ve metformi̇n i̇çeren çi̇ft katmanli tablet formülasyonlari
EP4037659C0 (en) PHARMACEUTICAL COMPOSITION CONTAINING ENZALUTAMIDE
CO2020015124A2 (es) Anticuerpo anti-tlr7 humano
EA201991265A1 (ru) Лекарственные формы с отсроченным высвобождением, содержащие диметилфумарат
TR201721824A2 (tr) Li̇nagli̇pti̇n ve metformi̇n i̇çeren modi̇fi̇ye salim sağlayan kombi̇nasyon
TR201914043A1 (tr) Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari
BR112017024126B8 (pt) Composições farmacêuticas, composto a micronizado e/ou pelo menos um sal farmaceuticamente aceitável micronizado do composto a e uso dos mesmos
CL2019001618A1 (es) Uso de compuestos de carbamato para prevención, alivio o tratamiento del trastorno bipolar.
TR201722367A2 (tr) Lakozami̇d i̇çeren parenteral uygulmaya yöneli̇k farmasöti̇k kompozi̇syonlar
TR201720515A2 (tr) Li̇nagli̇pti̇n i̇çeren bi̇r kati oral dozaj formu
TR201913472A2 (tr) Vi̇ldagli̇pti̇n ve metformi̇n i̇çeren bi̇r kombi̇nasyon
MX2018011222A (es) Ambrisentan para uso en el tratamiento de insuficiencia renal aguda.